CDSCO Panel Gives Conditional nod to Azelnidipine and Olmesartan FDC MD Bureau18 Jan 2021 6:51 PM ISTNew Delhi: Following the submission of bioequivalence (BE) study report by Akum Drugs, the Central Drug Standard Control...
FDA Approves Berotralstat for Hereditary Angioedema prophylaxis MD Bureau4 Dec 2020 6:30 PM ISTThe US Food and Drug Administration has approved oral, once-daily ORLADEYOâ„¢ (berotralstat) for prophylaxis to prevent attacks of hereditary angioedema...
Glenmark receives DGCI approval for launching Favipiravir in India Dr. Kamal Kant Kohli21 Jun 2020 6:14 PM ISTGlenmark Pharmaceuticals has received approvals from Drug Controller General of India to manufacture and market Favipiravir, an anti-viral drug, to...
FDA approves Celecoxib oral solution for acute treatment of migraine Dr. Kamal Kant Kohli8 May 2020 9:48 AM ISTThe Food and Drug Administration (FDA) has approved Elyxyb an oral solution formulation of celecoxib, for the acute treatment of migraine with or...
FDA approves Tabrecta for metastatic lung cancer Dr. Kamal Kant Kohli7 May 2020 3:26 AM ISTThe U.S. Food and Drug Administration has approved Tabrecta (capmatinib) for the treatment of adult patients with metastatic non-small cell lung...
FDA okays emergency use of remdesivir in severe cases of Covid 19 Dr. Kamal Kant Kohli2 May 2020 10:44 AM ISTThe US Food and drug administration has issued an emergency use authorization on for antiviral drug remdesivir for patients hospitalized with a...
Continue ACE inhibitors and ARBs in reduced GFR - it has CV benefits Dr. K B Aarthi22 March 2020 5:00 PM ISTContinuing ACE-I or ARB therapy in patients with declining kidney function may be associated with the cardiovascular benefit.
Favipiravir found very effective against COVID-19 in clinical trials Dr. K B Aarthi21 March 2020 11:30 AM ISTScientists at Beijing have announced that a new drug Favipiravir has been tested "very effective" against the world-sweeping COVID-19 caused by a...
DAPT has less bleeding risk than triple therapy in patients with AF after PCI Dr. K B Aarthi20 March 2020 10:15 AM ISTAntiplatelet therapy is an essential component for care for patients with AF after coronary stent placement. The aim is to mitigate stroke risk and to...
PPI's may increase the risk of fracture in children Dr. K B Aarthi19 March 2020 8:00 PM ISTUS: Proton pump inhibitors are widely used to treat acid reflux and other upper intestinal disorders in children as well as adults. Although PPIs have...
Aspirin may increase BMD and reduce fracture risk: Study Dr. K B Aarthi19 March 2020 7:30 PM ISTAspirin is an inhibitor of prostaglandin production and may influence the cellular basis of bone remodeling responsible for maintaining the material...
Triple drug inhaler may effectively reduce COPD exacerbations Dr. K B Aarthi19 March 2020 6:15 PM ISTDaily use of triple-drug FF/UMEC/VI inhaler led to significant reductions in moderate/severe COPD exacerbations, hospitalizations and death.
